Methotrexate for the treatment of recalcitrant genital and extragenital lichen sclerosus: A retrospective series

  • Adrian Cuellar-Barboza*
  • , Arjun M. Bashyam
  • , Rima I. Ghamrawi
  • , Divya Aickara
  • , Steven R. Feldman
  • , Rita O. Pichardo
  • *Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

343 Downloads (Pure)
OriginalsprogEngelsk
Artikelnummere13473
TidsskriftDermatologic Therapy
Vol/bind33
Udgave nummer4
ISSN1396-0296
DOI
StatusUdgivet - 1. jul. 2020

Finansiering

S. R. F. has received research, speaking, and/or consulting support from a variety of companies including Galderma, GSK/Stiefel, Almirall, Leo Pharma, Boehringer Ingelheim, Mylan, Celgene, Pfizer, Valeant, Abbvie, Samsung, Janssen, Lilly, Menlo, Merck, Novartis, Regeneron, Sanofi, Novan, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate, and National Psoriasis Foundation. He is founder and majority owner of www.DrScore.com and founder and part owner of Causa Research, a company dedicated to enhancing patients' adherence to treatment. R. O. P. has received consulting support from Abbvie. A. C.‐B., A. M. B., R. I. G., and D. A. have no conflicts to disclose.

Citationsformater